|4Apr 24, 4:13 PM ET

Coughlin Christina M. 4

4 · Rubius Therapeutics, Inc. · Filed Apr 24, 2020

Insider Transaction Report

Form 4
Period: 2020-04-22
Coughlin Christina M.
Chief Medical Officer
Transactions
  • Purchase

    Common Stock

    2020-04-22$5.52/sh+19,000$104,81419,000 total

Documents

1 file
  • 4
    edgar.xmlPrimary

    FORM 4 -